Microbiome Therapeutics Market to Touch USD 433.5 Mln by 2025, Predicts Grand View Research in Its Report Recently Added at MarketPublishers.com

23 Dec 2016 • by Natalie Aster

LONDON – Spurred by the rising funding along with favourable government initiatives to support research activities, the world’s microbiome therapeutics market is poised to see remarkable growth in the years ahead. The market value is anticipated to amount to USD 433.5 million by the year 2025.

The US government invested more than USD 121 million in the development of Microbiome Initiative, which got additional USD 100 million from the Bill and Melinda Gates Foundation.

Presence of strong microbiome drug pipeline will also give impetus to robust growth in the world’s microbiome therapeutics market. Key market participants are signing collaborative agreements with research institutes and venture capital firms in order to enhance therapeutics pipeline by developing safe and efficient drugs.

In the previous year, the fecal microbial transplant (FMT) segment captured the biggest share of the overall microbiome therapeutics, due to easy availability and also introduction of FMT capsules by Open Biome. Furthermore, no commercial microbiome drugs are presently available, and FMT is the only therapy for treatment.

Regionally, North America took lead in the worldwide market for microbiome therapeutics in the past year, primarily due to presence of outstanding companies, ongoing research activities and also established healthcare infrastructure. Meanwhile, APAC is set to increase at a tremendous pace in the upcoming years, driven by expanding FMT adoption in the region especially in China and India.

Some of the top market players include Seres Therapeutics, Second Genome, MicroBiome Therapeutics, ENTEROME Bioscience, Rebiotix, MaaT Pharma, Ritter Pharmaceuticals and OpenBiome.

New report “Microbiome Therapeutics Market By Type, By Application, By Region, And Segment Forecasts, 2014 - 2025” by Grand View Research provides a clear understanding of the current scenario in the world’s microbiome therapeutics market. It delves into the major market segments, covers competitive landscape and regulative environment, examines the key market growth limiters and drivers and also outlines top challenges and opportunities. The report covers noteworthy trends and presents an all-round future outlook for the market up to 2025.

Other reports by Grand View Research are available in this Market Publishers’ catalogue.

CONTACTS

The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com